ZA965527B - 1-Phenylalkyl-1,2,3,6-tetrahydropyridines - Google Patents

1-Phenylalkyl-1,2,3,6-tetrahydropyridines

Info

Publication number
ZA965527B
ZA965527B ZA965527A ZA965527A ZA965527B ZA 965527 B ZA965527 B ZA 965527B ZA 965527 A ZA965527 A ZA 965527A ZA 965527 A ZA965527 A ZA 965527A ZA 965527 B ZA965527 B ZA 965527B
Authority
ZA
South Africa
Prior art keywords
alkyl
alkoxy
substd
opt
alkoxycarbonyl
Prior art date
Application number
ZA965527A
Other languages
English (en)
Inventor
Domenico Badone
Marco Baroni
Rosanna Gardamone
Jaqueline Fournier
Umberto Guzzi
Alessandra Ielmini
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA965527B publication Critical patent/ZA965527B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
ZA965527A 1995-06-28 1996-06-28 1-Phenylalkyl-1,2,3,6-tetrahydropyridines ZA965527B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507760A FR2736053B1 (fr) 1995-06-28 1995-06-28 Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Publications (1)

Publication Number Publication Date
ZA965527B true ZA965527B (en) 1997-01-24

Family

ID=9480466

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA965527A ZA965527B (en) 1995-06-28 1996-06-28 1-Phenylalkyl-1,2,3,6-tetrahydropyridines

Country Status (29)

Country Link
US (1) US5981754A (cs)
EP (2) EP0837848B1 (cs)
JP (2) JP3147906B2 (cs)
KR (1) KR100460581B1 (cs)
CN (1) CN1153765C (cs)
AT (1) ATE223897T1 (cs)
AU (1) AU715090B2 (cs)
BR (1) BR9608662A (cs)
CA (1) CA2225746C (cs)
CY (1) CY2312B1 (cs)
CZ (1) CZ291075B6 (cs)
DE (1) DE69623631T2 (cs)
DK (1) DK0837848T3 (cs)
EE (1) EE03870B1 (cs)
ES (1) ES2183965T3 (cs)
FR (1) FR2736053B1 (cs)
HU (1) HUP9900055A3 (cs)
IL (1) IL122159A (cs)
IS (1) IS1999B (cs)
NO (1) NO310144B1 (cs)
NZ (1) NZ312723A (cs)
PL (2) PL187087B1 (cs)
PT (1) PT837848E (cs)
RU (1) RU2163237C2 (cs)
SK (2) SK283707B6 (cs)
TR (1) TR199701710T1 (cs)
UA (1) UA62914C2 (cs)
WO (1) WO1997001536A1 (cs)
ZA (1) ZA965527B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762514B1 (fr) * 1997-04-29 1999-10-22 Sanofi Sa Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
FR2771006B1 (fr) * 1997-11-14 2000-12-01 Sanofi Sa Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR2771007B1 (fr) * 1997-11-14 2000-12-01 Sanofi Sa Association de principes actifs pour le traitement de la demence senile du type alzheimer
CO4980891A1 (es) * 1997-11-14 2000-11-27 Sanofi Sa Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
EP1087962A4 (en) * 1998-06-19 2001-10-04 Lilly Co Eli PRODUCTION OF HETEROARYL COMPOUNDS
FR2803593B1 (fr) * 2000-01-06 2002-02-15 Sanofi Synthelabo Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
US7186720B2 (en) 2001-04-20 2007-03-06 Sanofi-Aventis Tetrahydropyridyl-alkyl-heterocycles, method for preparing the same and pharmaceutical compositions containing the same
FR2823748B1 (fr) * 2001-04-20 2004-02-20 Sanofi Synthelabo Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2840896B1 (fr) * 2002-06-18 2005-04-08 Sanofi Synthelabo Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2510170C (en) * 2002-12-16 2011-05-24 Mitsubishi Pharma Corporation 3-substituted-4-pyrimidone derivatives
US7632950B2 (en) 2003-08-18 2009-12-15 Fujifilm Finechemicals Co., Ltd Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them
TWI350168B (en) 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
JP2008504279A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
MXPA06014574A (es) 2004-06-24 2007-03-12 Incyte Corp Piperidinas n-sustituidas y su uso como farmaceuticos.
CA2569507A1 (en) * 2004-06-24 2006-02-02 Incyte Corporation Amido compounds and their use as pharmaceuticals
US20060009471A1 (en) * 2004-06-24 2006-01-12 Wenqing Yao Amido compounds and their use as pharmaceuticals
JP2008504280A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション ２−メチルプロパンアミドおよびその医薬としての使用
WO2006020598A2 (en) * 2004-08-10 2006-02-23 Incyte Corporation Amido compounds and their use as pharmaceuticals
TWI400239B (zh) * 2004-11-10 2013-07-01 Incyte Corp 內醯胺化合物及其作為醫藥品之用途
US8110581B2 (en) * 2004-11-10 2012-02-07 Incyte Corporation Lactam compounds and their use as pharmaceuticals
BRPI0518281A2 (pt) * 2004-11-18 2008-11-18 Incyte Corp inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos
FR2883285B1 (fr) * 2005-03-17 2007-05-18 Sanofi Aventis Sa Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
JP4864342B2 (ja) * 2005-04-27 2012-02-01 北興化学工業株式会社 ビアリール化合物の製造方法
WO2007038138A2 (en) * 2005-09-21 2007-04-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
NZ568446A (en) * 2005-12-05 2011-12-22 Incyte Corp Lactam compounds and methods of using the same as modulators of 11-beta hydroxyl steroid dehydrogenase 1
WO2007084314A2 (en) * 2006-01-12 2007-07-26 Incyte Corporation MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2007089683A1 (en) * 2006-01-31 2007-08-09 Incyte Corporation Amido compounds and their use as pharmaceuticals
TW200808807A (en) * 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007103719A2 (en) * 2006-03-03 2007-09-13 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
CA2649677A1 (en) * 2006-05-01 2007-11-15 Incyte Corporation Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
JP2009537564A (ja) * 2006-05-17 2009-10-29 インサイト・コーポレイション １１−βヒドロキシルステロイドデヒドロゲナーゼタイプＩの複素環阻害剤およびそれを用いる方法
CL2008001839A1 (es) 2007-06-21 2009-01-16 Incyte Holdings Corp Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
CN101945848A (zh) 2007-12-20 2011-01-12 英维沃医药有限公司 四取代的苯
EP2526081B1 (de) * 2010-01-19 2015-07-01 Bayer Intellectual Property GmbH Verfahren zur herstellung von aryl- und heteroarylessigsäure-derivaten
US10858351B2 (en) 2017-04-26 2020-12-08 Alberta Research Chemicals Inc. Substituted tetrahydropyridine derivatives as IDO-1 inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DE4325855A1 (de) * 1993-08-02 1995-02-09 Boehringer Ingelheim Kg Neue Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CZ291075B6 (cs) 2002-12-11
EE9700348A (et) 1998-06-15
WO1997001536A1 (fr) 1997-01-16
CY2312B1 (en) 2003-11-14
EE03870B1 (et) 2002-10-15
FR2736053B1 (fr) 1997-09-19
BR9608662A (pt) 1999-05-04
SK283707B6 (sk) 2003-12-02
HUP9900055A3 (en) 1999-11-29
IL122159A (en) 2001-06-14
SK285433B6 (sk) 2007-01-04
CZ422297A3 (cs) 1998-04-15
IL122159A0 (en) 1998-04-05
EP1216996A2 (fr) 2002-06-26
PL192353B1 (pl) 2006-10-31
NO976079D0 (no) 1997-12-23
MX9710472A (es) 1998-03-31
KR19990028431A (ko) 1999-04-15
DK0837848T3 (da) 2003-01-06
JP3147906B2 (ja) 2001-03-19
CN1189154A (zh) 1998-07-29
ES2183965T3 (es) 2003-04-01
US5981754A (en) 1999-11-09
PL324216A1 (en) 1998-05-11
NO310144B1 (no) 2001-05-28
RU2163237C2 (ru) 2001-02-20
DE69623631D1 (en) 2002-10-17
JP2001114763A (ja) 2001-04-24
PT837848E (pt) 2002-12-31
AU715090B2 (en) 2000-01-13
FR2736053A1 (fr) 1997-01-03
JPH11506118A (ja) 1999-06-02
NO976079L (no) 1997-12-23
EP0837848A1 (fr) 1998-04-29
CA2225746C (en) 2004-05-18
TR199701710T1 (xx) 1998-05-21
IS4641A (is) 1997-12-23
PL187087B1 (pl) 2004-05-31
HUP9900055A2 (hu) 1999-04-28
EP1216996A3 (fr) 2003-10-15
ATE223897T1 (de) 2002-09-15
HK1014952A1 (en) 1999-10-08
JP3302351B2 (ja) 2002-07-15
CA2225746A1 (en) 1997-01-16
AU6461996A (en) 1997-01-30
DE69623631T2 (de) 2003-08-07
UA62914C2 (en) 2004-01-15
CN1153765C (zh) 2004-06-16
SK178197A3 (en) 1998-07-08
KR100460581B1 (ko) 2005-04-14
NZ312723A (en) 1999-10-28
EP0837848B1 (fr) 2002-09-11
IS1999B (is) 2005-04-15

Similar Documents

Publication Publication Date Title
ZA965527B (en) 1-Phenylalkyl-1,2,3,6-tetrahydropyridines
GR3029408T3 (en) Novel piperidine derivatives, useful as neurokinin receptor antagonists
NO914218L (no) Synergistiske ultrafiolettabsorberblandinger inneholdendehydroksyaryltriaziner og tetraalkylpiperidiner
IL115572A0 (en) Novel substituted 4-(azanaphthoylamino)-piperidines salts of these and pharmaceutical compositions containing them
MX9701679A (es) Derivados de piperidina como antagonistas de la neuroquinina.
FI955184A0 (fi) Bentsyylipiperidiinijohdannaiset
GR3036173T3 (en) Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
IL112832A0 (en) Insecticidal n-(substituted arylmethyl)-4-[bis-substituted phenyl)methyl]piperidines
ATE285403T1 (de) Verfahren zur herstellung von n-((4- phenyl)methylphenyl)piperazinen
TW341570B (en) Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
PL310850A1 (en) Novel solar filters, cosmetic protective compositions containing them and their application
UA41928C2 (uk) Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань
AU6753694A (en) 4-aryloxy- and 4-arylthiopiperidine derivatives
IL116387A (en) 5-acyl-1,4-dihydropyridines for control of disorders of CNS with modulating action on potassium channels certain such novel compounds and their preparation
IL119297A (en) 2,3-Dihydroxypropyl-2-(1-oxoalkyl) amino-2-deoxyglucopyranosides a process for their preparation and compositions containing them
NZ336033A (en) 4-substituted 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
RU99115083A (ru) 1-фенилалкил-1,2,3,6-тетрагидропиридины для лечения болезни альцгеймера
DE3867563D1 (en) 2-amino-5-hydroxy-4-pyrimidone.
EP0372582A3 (en) 6-aminoalkyl carbapenems
IL112282A (en) Preparation of chloropyridines and certain novel chloropyridinium chlorides used therefor
IT1196751B (it) Alogeno e ciano derivati dell'acido glutammico ed aspartico ad attivita antagonista su polipeptidi bioattivi e procedimento per la loro preparazione
IT1201455B (it) Derivati piridinici sostituiti